Rare diseases
Investigational molecules
Locations
Back to Hungary556 clinical trials in Debrecen, Hungary across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Efficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
HungaryA study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.
HungaryA study to evaluate the safety and effectiveness of galvokimig in adults with moderate to severe atopic dermatitis
HungaryA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
HungaryEfficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
HungaryA study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese
HungaryA study to test if tibulizumab works and is safe for adults with systemic sclerosis
HungaryA Study of Cagrilintide and Semaglutide for Weight Loss in People with Type 2 Diabetes and Overweight or Obesity
HungaryStudy of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis
HungaryStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
HungaryStudy of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks
HungaryStudy of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)
HungaryThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies evaluating novel treatments for plaque psoriasis and chronic urticaria. Multiple trials are investigating innovative therapies for both moderate to severe cases, including genital manifestations.
Focus on long-term safety and efficacy of new therapeutic agents for chronic skin conditions.
Leading research into heart failure prevention and cardiovascular disease management. Trials examining innovative treatments and preventive approaches for high-risk patients.
Emphasis on reducing major cardiovascular events and improving patient outcomes.
Groundbreaking research addressing obesity and type 2 diabetes. Studies evaluating combination therapies and novel approaches for weight management in diverse patient populations.
Investigation of treatments combining weight reduction with diabetes management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
